Phylos Bioscience
PrivateLast Round
Debt
Dec 31, 2025
Total Funding Raised
$29.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phylos Bioscience is a crop science company that develops and sells advanced cannabis and hemp genetics, including F1 hybrid seeds and natural THCV products, to empower growers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phylos Bioscience Comparables
Compare Phylos Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dewey Scientific | 85% | |
| Medicinal Genomics | 84% | |
| MyFloraDNA, Inc. | 83% | |
Phylos Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 31, 2025 | ||||
| Strategic | Dec 31, 2024 | ||||
| Seed Round | Jan 24, 2024 | ||||
| Convertible Debt | May 25, 2023 | ||||
| Series B | Feb 1, 2022 | ||||
VC Round | May 29, 2018 |
Key People
Founding team and executive leadership
Phylos Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accomplice | Series B |
| Entourage Effect Capital | Series B |
| Merida Capital Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 49, 98% of headcount.
- Jul 13, 2026
Open roles increased to 10, 3.3x the trailing average.
Phylos Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phylos Bioscience's valuation, stock price, and market status.